Hansa Biopharma AB
OTC:HNSBF

Watchlist Manager
Hansa Biopharma AB Logo
Hansa Biopharma AB
OTC:HNSBF
Watchlist
Price: 2.91 USD
Market Cap: 317.7m USD

Operating Margin
Hansa Biopharma AB

-305.7%
Current
-416%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-305.7%
=
Operating Profit
-546m
/
Revenue
178.6m

Operating Margin Across Competitors

No Stocks Found

Hansa Biopharma AB
Glance View

Market Cap
317.7m USD
Industry
Biotechnology

Hansa Biopharma AB focuses on novel immunomodulatory enzymes, which treats rare immunoglobulin G-mediated autoimmune conditions, transplant rejection and cancer. The company is headquartered in Lund, Skane and currently employs 141 full-time employees. The company went IPO on 2007-10-17. The Company’s operations consist of research and development for drug discovery. The firm conducts several projects, among which primary are IdeS (Immunoglobulin G-degrading enzyme of Streptococcus pyogenes) and HBP-assay (Heparin Binding Protein-assay). IdeS’s goal is to enable transplantation that prevents antibody-mediated rejection. HBP-assay is a diagnostic method that aims to predict severe sepsis in patients with infectious disease symptoms. The Company’s patent portfolio consists of several patent families that geographically cover numerous jurisdictions, including the United States, Europe and Japan.

HNSBF Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-305.7%
=
Operating Profit
-546m
/
Revenue
178.6m
What is the Operating Margin of Hansa Biopharma AB?

Based on Hansa Biopharma AB's most recent financial statements, the company has Operating Margin of -305.7%.

Back to Top